GlucoTrack, Inc.

GCTK Healthcare Medical Instruments & Supplies

In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.

0.73 0.10 −12.05%
Market cap
$840.0K
P/E
0.0×
Fwd P/E
−17.8×
Dividend yield
—
F-score
3/9
Altman Z
26019048.63
Beneish M
2.40
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
1.53 1.61 0.85 0.46
Net Debt/EBITDA
1.08 1.19 0.09 (0.25)
Debt/Equity
1.18 1.21 (4.19) (1.11)
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(78.13) (95.56) (37.04) (10.82)
Book value per Share
45.85 68.31 (7.79) (5.21)
Free Cash Flow
(4.69) (3.96) (4.05) (3.62)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates